Broad-spectrum antiviral drug development
Kimer Med has raised $8.7M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
Kimer Med is headquartered in Nelson, New Zealand.
Broad-spectrum antiviral drug development
Kimer Med is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kimer Med — Funding & Investors." VCBacked, June 6, 2024, https://www.vcbacked.co/company/kimer-med. Accessed July 20, 2026.
VCBacked. (2024). Kimer Med — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/kimer-med
{{cite web |title=Kimer Med — Funding & Investors |url=https://www.vcbacked.co/company/kimer-med |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated